Showing results (171-180 of 187) with videos related to
Sort By:
Pageof 19
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 6, 2016
Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysisYasumasa Sugita, Chikako Ohwada, Takeharu Kawaguchi, et al.Journal of Cancer Research and Clinical Oncology|December 25, 2013
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)Wasaburo Koizumi, Yeul Hong Kim, Masashi Fujii, et al.Nature Immunology|June 22, 2021
A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROSMotoi Yamashita, Hye Sun Kuehn, Kazuki Okuyama, et al.Experimental Hematology|August 19, 2021
Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencingKenji Kimura, Shokichi Tsukamoto, Kanji Miyazaki, et al.Leukemia Research|October 5, 2016
Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemiaRyo Shimizu, Tomoya Muto, Kazumasa Aoyama, et al.American Journal of Hematology|July 18, 2018
Clonal immunoglobulin λ light-chain gene rearrangements detected by next generation sequencing in POEMS syndromeChika Kawajiri-Manako, Naoya Mimura, Masaki Fukuyo, et al.British Journal of Cancer|August 4, 2018
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancerYoichi Aoki, Kazunori Ochiai, Soyi Lim, et al.British Journal of Haematology|August 11, 2021
Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohortTatsuzo Mishina, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, et al.Experimental Hematology|March 3, 2022
A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiencyHisaya Kato, Yoshiro Maezawa, Dai Nishijima, et al.Scientific Reports|January 23, 2021
The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cellsYurie Nagai, Naoya Mimura, Ola Rizq, et al.Pageof 19